Rhumbline Advisers Ani Pharmaceuticals Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Rhumbline Advisers holds 42,210 shares of ANIP stock, worth $2.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,210
Previous 42,170 0.09%
Holding current value
$2.39 Million
Previous $2.69 Million 6.22%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$54.33 - $65.72 $2,173 - $2,628
40 Added 0.09%
42,210 $2.52 Million
Q2 2024

Aug 01, 2024
BUY
$58.53 - $68.82 $328,763 - $386,561
5,617 Added 15.37%
42,170 $2.69 Million
Q1 2024

May 09, 2024
SELL
$54.2 - $69.69 $75,663 - $97,287
-1,396 Reduced 3.68%
36,553 $2.53 Million
Q4 2023

Feb 08, 2024
SELL
$48.72 - $65.43 $84,529 - $113,521
-1,735 Reduced 4.37%
37,949 $2.09 Million
Q3 2023

Nov 09, 2023
BUY
$50.28 - $64.61 $236,316 - $303,667
4,700 Added 13.43%
39,684 $2.3 Million
Q2 2023

Aug 08, 2023
BUY
$37.29 - $53.83 $37,252 - $53,776
999 Added 2.94%
34,984 $1.88 Million
Q1 2023

May 11, 2023
BUY
$37.61 - $45.72 $89,587 - $108,905
2,382 Added 7.54%
33,985 $1.35 Million
Q4 2022

Feb 14, 2023
BUY
$31.9 - $41.95 $29,539 - $38,845
926 Added 3.02%
31,603 $1.27 Million
Q3 2022

Nov 10, 2022
BUY
$29.83 - $38.01 $14,378 - $18,320
482 Added 1.6%
30,677 $986,000
Q2 2022

Aug 11, 2022
BUY
$23.09 - $33.46 $98,802 - $143,175
4,279 Added 16.51%
30,195 $896,000
Q1 2022

May 12, 2022
BUY
$26.91 - $47.15 $29,493 - $51,676
1,096 Added 4.42%
25,916 $728,000
Q4 2021

Feb 10, 2022
SELL
$32.97 - $56.85 $209,985 - $362,077
-6,369 Reduced 20.42%
24,820 $1.14 Million
Q3 2021

Nov 12, 2021
SELL
$26.48 - $35.99 $86,245 - $117,219
-3,257 Reduced 9.46%
31,189 $1.02 Million
Q2 2021

Aug 05, 2021
SELL
$31.86 - $38.6 $12,043 - $14,590
-378 Reduced 1.09%
34,446 $1.21 Million
Q1 2021

May 06, 2021
BUY
$28.4 - $36.14 $32,660 - $41,561
1,150 Added 3.42%
34,824 $1.26 Million
Q4 2020

Feb 10, 2021
BUY
$23.69 - $31.47 $76,731 - $101,931
3,239 Added 10.64%
33,674 $978,000
Q3 2020

Nov 12, 2020
SELL
$26.38 - $33.1 $35,955 - $45,115
-1,363 Reduced 4.29%
30,435 $859,000
Q2 2020

Aug 13, 2020
BUY
$29.93 - $50.1 $2,933 - $4,909
98 Added 0.31%
31,798 $1.03 Million
Q1 2020

May 06, 2020
BUY
$30.35 - $67.14 $22,641 - $50,086
746 Added 2.41%
31,700 $1.29 Million
Q4 2019

Feb 05, 2020
BUY
$55.65 - $79.83 $123,376 - $176,983
2,217 Added 7.71%
30,954 $1.91 Million
Q3 2019

Oct 23, 2019
BUY
$64.7 - $85.39 $143,698 - $189,651
2,221 Added 8.38%
28,737 $2.09 Million
Q2 2019

Aug 14, 2019
BUY
$67.77 - $82.2 $165,087 - $200,239
2,436 Added 10.12%
26,516 $2.18 Million
Q1 2019

May 01, 2019
SELL
$45.83 - $70.54 $11,869 - $18,269
-259 Reduced 1.06%
24,080 $1.7 Million
Q4 2018

Jan 31, 2019
BUY
$41.17 - $56.44 $149,941 - $205,554
3,642 Added 17.6%
24,339 $1.1 Million
Q3 2018

Nov 07, 2018
SELL
$52.95 - $71.34 $61,898 - $83,396
-1,169 Reduced 5.35%
20,697 $1.17 Million
Q2 2018

Aug 06, 2018
BUY
$56.38 - $68.08 $78,875 - $95,243
1,399 Added 6.84%
21,866 $1.46 Million
Q1 2018

May 02, 2018
BUY
$56.98 - $72.41 $38,632 - $49,093
678 Added 3.43%
20,467 $1.19 Million
Q4 2017

Feb 09, 2018
BUY
$53.3 - $74.56 $149,613 - $209,289
2,807 Added 16.53%
19,789 $1.28 Million
Q3 2017

Nov 06, 2017
BUY
$43.46 - $52.49 $738,037 - $891,385
16,982
16,982 $891,000

Others Institutions Holding ANIP

# of Institutions
211
Shares Held
18.8M
Call Options Held
11.7K
Put Options Held
10.5K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email